PCRX — Pacira BioSciences, Inc.Today's name, from the SEC's present-day ticker list — a present-day mapping, not the name as of each filing.
- Congress trades
- 10
- all time
- Members · 12m
- 0
- 0 buys · 0 sells · by trade date
- Latest filing
- 08-26
- 2021-08-26
- Rows filed past the STOCK Act's 45-day window, stated on the row, never editorialised; both dates and the receipt stay on every row.
- 10
- 13F holders
- 226
- all listed · 2026-03-31
Congress: statutory ranges, filed up to 45 days after the trade · 13F: quarter-end snapshots, filed up to 45 days lateras of 2026-10-29
Congress · disclosure timeline
By trade date · 24 months · 0 rows ▲ buy, ▼ sell; height = lower bound (log scale). Trade date, not filing date — the filing lag is in the table below.No dated PCRX rows fall inside the trailing 24 months by trade date.
Members active in PCRX
12 months · most active first Rows = number of disclosures, not dollars. Net = lower bound of the net range. Committees as of each member's latest trade in the window (roster snapshot 2026-10-29).No member disclosed PCRX in the trailing 12 months.
| Filed | Member | Side · Owner | Traded · Lag | Amount | Range · Flags | Src |
|---|---|---|---|---|---|---|
| 2021-08-26 | Tom Malinowski D–NJ-7 | BUY | Traded 01-25 LATE·213d | $1K–$15K | ||
| 2021-08-26 | Tom Malinowski D–NJ-7 | BUY | Traded 2019-05-31 LATE·818d | $15K–$50K | ||
| 2021-06-23 | Tom Malinowski D–NJ-7 | BUY | Traded 05-06 LATE·48d | $1K–$15K | ||
| 2021-06-12 | Tom Malinowski D–NJ-7 | BUY | Traded 04-20 LATE·53d | $1K–$15K | ||
| 2021-03-05 | Tom Malinowski D–NJ-7 | BUY | Traded 01-15 LATE·49d | $1K–$15K | ||
| 2021-03-05 | Tom Malinowski D–NJ-7 | BUY | Traded 2020-11-02 LATE·123d | $1K–$15K | ||
| 2021-03-05 | Tom Malinowski D–NJ-7 | BUY | Traded 2019-09-26 LATE·526d | $15K–$50K | ||
| 2021-03-05 | Tom Malinowski D–NJ-7 | BUY | Traded 2019-08-23 LATE·560d | $1K–$15K | ||
| 2021-03-05 | Tom Malinowski D–NJ-7 | BUY | Traded 2019-05-31 LATE·644d | $15K–$50K | ||
| 2021-03-05 | Tom Malinowski D–NJ-7 | BUY | Traded 2019-05-30 LATE·645d | $15K–$50K |
13F holders · Quarter ended 2026-03-31Newest filing in this build: 2026-07-31. Per-row filing dates are on each receipt. · longs only
| # | Filer | Value | Securities | Flags | derived by Public Filings from this build's reviewed ticker-mapping holders list for this share class; that list carries each holder's share count, share change and filed date, which this table does not show, but no document links — the EDGAR link opens the filer's 13F list·§ |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | $152M | 1 | derived ·§ EDGAR ↗ | |
| 2 | Doma Perpetual Capital Management LLC | $62.8M | 1 | derived ·§ EDGAR ↗ | |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | $56.5M | 1 | derived ·§ EDGAR ↗ | |
| 4 | DIMENSIONAL FUND ADVISORS LP | $46.6M | 1 | derived ·§ EDGAR ↗ | |
| 5 | D. E. Shaw & Co., Inc. | $44.8M | 1 | derived ·§ EDGAR ↗ | |
| 6 | STATE STREET CORP | $43.4M | 1 | derived ·§ EDGAR ↗ | |
| 7 | RENAISSANCE TECHNOLOGIES LLC | $41.3M | 1 | derived ·§ EDGAR ↗ | |
| 8 | VANGUARD CAPITAL MANAGEMENT LLC | $40.3M | 1 | derived ·§ EDGAR ↗ | |
| 9 | MORGAN STANLEY | $31.5M | 1 | derived ·§ EDGAR ↗ | |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | $25.9M | 1 | derived ·§ EDGAR ↗ | |
| 11 | AMERICAN CENTURY COMPANIES INC | $18.9M | 1 | derived ·§ EDGAR ↗ | |
| 12 | CITADEL ADVISORS LLC | $18.0M | 1 | derived ·§ EDGAR ↗ | |
| 13 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $16.5M | 1 | derived ·§ EDGAR ↗ | |
| 14 | GAGNON SECURITIES LLC | $14.0M | 1 | derived ·§ EDGAR ↗ | |
| 15 | UBS Group AG | $12.7M | 1 | derived ·§ EDGAR ↗ | |
| 16 | TWO SIGMA INVESTMENTS, LP | $11.9M | 1 | derived ·§ EDGAR ↗ | |
| 17 | NORTHERN TRUST CORP | $11.7M | 1 | derived ·§ EDGAR ↗ | |
| 18 | WELLINGTON MANAGEMENT GROUP LLP | $10.8M | 1 | derived ·§ EDGAR ↗ | |
| 19 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | $9.3M | 1 | derived ·§ EDGAR ↗ | |
| 20 | Bridge City Capital, LLC | $9.1M | 1 | derived ·§ EDGAR ↗ | |
| 21 | DEUTSCHE BANK AG\ | $8.9M | 1 | derived ·§ EDGAR ↗ | |
| 22 | Gagnon Advisors, LLC | $8.0M | 1 | derived ·§ EDGAR ↗ | |
| 23 | EASTERLY INVESTMENT PARTNERS LLC | $7.7M | 1 | derived ·§ EDGAR ↗ | |
| 24 | Hillsdale Investment Management Inc. | $7.5M | 1 | derived ·§ EDGAR ↗ | |
| 25 | Bank of New York Mellon Corp | $6.8M | 1 | derived ·§ EDGAR ↗ |
Show all 226 holders
| # | Filer | Value | Securities | Flags | Src·§ |
|---|
All 189 13F filers reporting this share class are listed. Method ↗
Crowding — not available in this build. No holder rows for the selected period, so no percentile can be ranked.
Congress ↔ notable managers · PCRX
Congress · last 90 days
- Buyers
- 0 — —
- Sellers
- 0 — —
filed 2026-07-31 → 2026-10-29 · statutory ranges
Notable managers · quarter ended 2026-03-31
- Adding
- 1 Gotham Asset Management $1.0M held
- Trimming
- 1 Caxton Associates $798K held
by shares · $ = value heldNEW + ADD vs TRIM + EXIT, by share count. $ = reported value now, not the change. · PACIRA BIOSCIENCES INC
| Date | Who | Change | Size |
|---|---|---|---|
| 2026-05-15 | Gotham Asset Management 13F | ADD | +12,011 sh |
| 2026-05-14 | Caxton Associates 13F | TRIM | −14,683 sh |
2 newest, by filing date · 13F rows are quarter-end snapshots, not trades
Congress vs filers
12 monthsCongress net (rows)no rows
Congress net ($ bound)$0
Filersnot computedThe filer side needs per-issuer quarter-over-quarter actions, which the published aggregate does not carry for this issuer. Convergence and divergence are stated only when both sides are computed.